BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 26891306)

  • 1. Development of a Rapid Throughput Assay for Identification of hNav1.7 Antagonist Using Unique Efficacious Sodium Channel Agonist, Antillatoxin.
    Zhao F; Li X; Jin L; Zhang F; Inoue M; Yu B; Cao Z
    Mar Drugs; 2016 Feb; 14(2):. PubMed ID: 26891306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antillatoxin is a sodium channel activator that displays unique efficacy in heterologously expressed rNav1.2, rNav1.4 and rNav1.5 α subunits.
    Cao Z; Gerwick WH; Murray TF
    BMC Neurosci; 2010 Dec; 11():154. PubMed ID: 21156065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
    Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
    Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE.
    Li T; Lu G; Chiang EY; Chernov-Rogan T; Grogan JL; Chen J
    PLoS One; 2017; 12(7):e0180154. PubMed ID: 28683073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
    Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
    Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a thallium flux-based functional assay for the sodium channel NaV1.7 and its utility for lead discovery and compound profiling.
    Du Y; Days E; Romaine I; Abney KK; Kaufmann K; Sulikowski G; Stauffer S; Lindsley CW; Weaver CD
    ACS Chem Neurosci; 2015 Jun; 6(6):871-8. PubMed ID: 25879403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the interaction site for the tarantula toxin hainantoxin-IV (β-TRTX-Hn2a) in the voltage sensor module of domain II of voltage-gated sodium channels.
    Cai T; Luo J; Meng E; Ding J; Liang S; Wang S; Liu Z
    Peptides; 2015 Jun; 68():148-56. PubMed ID: 25218973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a high-throughput fluorescent no-wash sodium influx assay.
    Tay B; Stewart TA; Davis FM; Deuis JR; Vetter I
    PLoS One; 2019; 14(3):e0213751. PubMed ID: 30856233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of sodium channel blockers by membrane potential measurements in cerebellar neurons: prediction of compound preference for the open/inactivated state.
    Kolok S; Nagy J; Szombathelyi Z; Tarnawa I
    Neurochem Int; 2006 Nov; 49(6):593-604. PubMed ID: 16777267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the pharmacological properties of rat Na(V)1.8 with rat Na(V)1.2a and human Na(V)1.5 voltage-gated sodium channel subtypes using a membrane potential sensitive dye and FLIPR.
    Vickery RG; Amagasu SM; Chang R; Mai N; Kaufman E; Martin J; Hembrador J; O'Keefe MD; Gee C; Marquess D; Smith JA
    Recept Channels; 2004; 10(1):11-23. PubMed ID: 14769548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. μ-conotoxin TsIIIA, a peptide inhibitor of human voltage-gated sodium channel hNa
    Yang M; Zhou M
    Toxicon; 2020 Oct; 186():29-34. PubMed ID: 32758497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antillatoxin is a marine cyanobacterial toxin that potently activates voltage-gated sodium channels.
    Li WI; Berman FW; Okino T; Yokokawa F; Shioiri T; Gerwick WH; Murray TF
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7599-604. PubMed ID: 11416227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa
    Neff RA; Flinspach M; Gibbs A; Shih AY; Minassian NA; Liu Y; Fellows R; Libiger O; Young S; Pennington MW; Hunter MJ; Wickenden AD
    J Biol Chem; 2020 Jan; 295(5):1315-1327. PubMed ID: 31871053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening against protein:protein interaction interfaces reveals anti-cancer therapeutics as potent modulators of the voltage-gated Na
    Wadsworth PA; Folorunso O; Nguyen N; Singh AK; D'Amico D; Powell RT; Brunell D; Allen J; Stephan C; Laezza F
    Sci Rep; 2019 Nov; 9(1):16890. PubMed ID: 31729429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Makatoxin-3, a thermostable Nav1.7 agonist from Buthus martensii Karsch (BmK) scorpion elicits non-narcotic analgesia in inflammatory pain models.
    Chen Y; Xu E; Sang M; Wang Z; Zhang Y; Ye J; Zhou Q; Zhao C; Hu C; Lu W; Cao P
    J Ethnopharmacol; 2022 Apr; 288():114998. PubMed ID: 35063590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
    Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
    Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. µ-Conotoxins Targeting the Human Voltage-Gated Sodium Channel Subtype Na
    McMahon KL; Tran HNT; Deuis JR; Craik DJ; Vetter I; Schroeder CI
    Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of inhibition by chlorpromazine of the human pain threshold sodium channel, Na
    Lee SJ; Kim DH; Hahn SJ; Waxman SG; Choi JS
    Neurosci Lett; 2017 Feb; 639():1-7. PubMed ID: 28017662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veratridine modifies the gating of human voltage-gated sodium channel Nav1.7.
    Zhang XY; Bi RY; Zhang P; Gan YH
    Acta Pharmacol Sin; 2018 Nov; 39(11):1716-1724. PubMed ID: 29950616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lamotrigine on Na(v)1.4 voltage-gated sodium channels.
    Nakatani Y; Masuko H; Amano T
    J Pharmacol Sci; 2013; 123(2):203-6. PubMed ID: 24096830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.